Center for Molecular Medicine and Immunology-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2021

  1. Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

    Annals of Oncology, Vol. 32, Núm. 9, pp. 1148-1156